6505--Venlafaxine 24HR Sustained Action Capsules
Posted
Mar 24, 2026
Due Date
Mar 31, 2026
Location
N/A, N/A, N/A
Description
https://api.sam.gov/prod/opportunities/v1/noticedesc?noticeid=4af61343056c4afd98c7958e7f97419c
AI Summary
The solicitation requires offerors to submit a fully compliant subcontracting plan for a VA contract valued over $900,000. The plan must detail how subcontracting goals were developed, providing justification whenever a proposed goal is lower than the VA‑suggested goal or lower than the previous year’s achievement. Offerors must identify potential sources using specific websites, organizations, associations, or events, and indicate whether indirect costs are included in the dollar and percentage goals in accordance with FAR 52.219‑9(g). Evidence of substantial transformation—including API and final manufacturing processes—must be provided, and the offeror must specify the exact name and address of the manufacturing facility (or indicate distributor status). A currently approved commercial plan (company‑wide or division‑wide) or a new plan for approval must be submitted, with separate dollar and percentage goals for the base period and each option year, and must reflect total projected subcontract spend, including all indirect costs except those expressly excluded. In addition, the offeror must describe proactive, good‑faith efforts—both internal and external—to ensure equitable opportunities for small business, veteran‑owned, service‑disabled veteran‑owned, HUBZone, disadvantaged, and women‑owned concerns, listing specific organizations, events, and associations. The subcontracting program administrator’s name, contact information, and comprehensive duties (including timely eSRS reporting and plan submission 30 days before expiration) must be provided. All required FAR clauses (e.g., 52.204‑7, 52.214‑34, 52.214‑35) and VAAR references must be incorporated, and the offeror must acknowledge receipt of any solicitation amendment as instructed. Failure to include any essential information may result in delay or rejection of the offer.
Details
- Notice ID
- 4af61343056c4afd98c7958e7f97419c
- Solicitation Number
- 36E79726R0010
- NAICS Code
- 325412
- Classification Code
- 6505
Want to track opportunities like this?
Sign up for Kontratar to get AI-powered opportunity matching, ranking, and alerts.
Get Started FreeRelated opportunities
- 6505--Nitroglycerin Patches
VETERANS AFFAIRS, DEPARTMENT OF.VETERANS AFFAIRS, DEPARTMENT OF.NAC PHARMACEUTICALS (36E797)
- Filgrastim Biosimilar (VA-27-00012533)
VETERANS AFFAIRS, DEPARTMENT OF.VETERANS AFFAIRS, DEPARTMENT OF.NAC PHARMACEUTICALS (36E797)
- 6505--General Radioisotopes (Diagnostic & Therapeutic)
VETERANS AFFAIRS, DEPARTMENT OF.VETERANS AFFAIRS, DEPARTMENT OF.NETWORK CONTRACT OFFICE 19 (36C259)
- Epinephrine Injector
DEPT OF DEFENSE.DEFENSE LOGISTICS AGENCY.TROOP SUPPORT MEDICAL.DLA TROOP SUPPORT
- 6505--Sources Sought VISN2 DOWNSTATE GENERAL RADIOPHARMACEUTICALS
VETERANS AFFAIRS, DEPARTMENT OF.VETERANS AFFAIRS, DEPARTMENT OF.242-NETWORK CONTRACT OFFICE 02 (36C242)
- Medical Gas Cylinders, USP, Type I-DOT 3AA Steel
DEPT OF DEFENSE.DEFENSE LOGISTICS AGENCY.TROOP SUPPORT MEDICAL.DLA TROOP SUPPORT
- 6505--Request for Information (RFI) - Specialty Pharmacy – Pharmaceutical Prime Vendor (PPV) 2028
VETERANS AFFAIRS, DEPARTMENT OF.VETERANS AFFAIRS, DEPARTMENT OF.NAC PRIME VENDOR (36W797)
- 6505--Latanoprost Ophthalmic Solution (VA-27-00006027)
VETERANS AFFAIRS, DEPARTMENT OF.VETERANS AFFAIRS, DEPARTMENT OF.NAC PHARMACEUTICALS (36E797)